Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL vs DINOPROSTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPROSTADIL vs DINOPROSTONE: Safety Overview

Metric ALPROSTADIL DINOPROSTONE
Total FAERS Reports 2,800 723
Deaths Reported 60 63
Death Rate 2.1% 8.7%
Hospitalizations 210 181
Average Patient Age 62.5 yrs 28.7 yrs
% Female Patients 4.9% 91.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer ENDO USA, Inc. Ferring Pharmaceuticals Inc.
Route INTRACAVERNOUS VAGINAL
Marketing Status Prescription Discontinued